Publication
Proteomics in the assessment of the therapeutic response of antineoplastic drugs: strategies and practical applications
| dc.contributor.author | Torres, Vukosava Milic | |
| dc.contributor.author | Popovic, Lazar | |
| dc.contributor.author | Vaz, Fatima | |
| dc.contributor.author | Penque, Deborah | |
| dc.date.accessioned | 2016-10-06T12:31:48Z | |
| dc.date.available | 2016-10-06T12:31:48Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Uncovering mechanisms of unknown pathological mechanisms and body response to applied medication are the drive forces toward personalized medicine. In this post-genomic era, all eyes are tuned to proteomic field, searching for the answers and explanations by investigating the final physiological functional units – proteins and their proteoforms. Development of cutting-edge mass spectrometric technologies and powerful bioinformatics tools, allowed life-science community mining of disease-specific proteins as biomarkers, which are often hidden by high complexity of the samples and/or small abundance. Nowadays, there are several proteomics-based approaches to study the proteome. This chapter focuses on gold standard proteomics strategies and related issues towards candidate biomarker discovery, which may have diagnostic/prognostic as well as mechanistic utility. | pt_PT |
| dc.identifier.citation | In: Rueff J, Rodrigues AS (eds.). Cancer Drug Resistance: Overviews and Methods, Springer, 2016: 281-298 | pt_PT |
| dc.identifier.isbn | 978-1-4939-3347-1 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/4026 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.relation | http://www.springer.com/gp/book/9781493933457 | |
| dc.subject | Genomica Funcional | pt_PT |
| dc.subject | Monitorização de Drogas | pt_PT |
| dc.subject | Genómica Funcional e Estrutural | pt_PT |
| dc.subject | Cancer | pt_PT |
| dc.subject | Chemotherapeutic Response | pt_PT |
| dc.subject | Discovery-based Proteomics | pt_PT |
| dc.subject | Proteomics | pt_PT |
| dc.subject | Target-proteomics | pt_PT |
| dc.title | Proteomics in the assessment of the therapeutic response of antineoplastic drugs: strategies and practical applications | pt_PT |
| dc.type | book part | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 298 | pt_PT |
| oaire.citation.startPage | 281 | pt_PT |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | bookPart | pt_PT |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Proteomics & cancer drug resistance_ 2014 FINAL WITHOUT FUGURES_29_10_2014.pdf
- Size:
- 195.77 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
